Emerging reverse transcriptase inhibitors for the treatment of HIV infection in adults

Expert Opinion on Emerging Drugs
Claude FortinPatrick Yeni

Abstract

A combination of three or more antiretroviral drugs, commonly called 'highly active antiretroviral therapy' (HAART), has become the standard-of-care treatment for HIV-infected patients in the developed world. There are now 21 licensed anti-HIV drugs to choose from when starting a HAART regimen. The currently approved antiretroviral drugs fall into four categories: nucleoside/nucleotide reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, protease inhibitors and fusion inhibitors. Novel compounds currently in preclinical or clinical development are either focusing on new viral proteins or the same specific viral elements targeted by the available drugs. When developing new anti-HIV drugs of an already existing class, focus should be held on maximising potency, minimising toxicity, diminishing the risk for resistance development and producing effective drugs for patients who already have resistance to currently available drugs. In addition, pill burden should be ideally reduced to once-daily dosing, thereby enhancing a patient's adherence and reducing treatment costs. The present review focuses on emerging drugs to inhibit the reverse transcriptase of HIV.

References

Jun 13, 1998·Antimicrobial Agents and Chemotherapy·T FujiwaraY Hinuma
Jan 5, 1999·Bioorganic & Medicinal Chemistry Letters·S H ChenT W Doyle
Sep 2, 2000·Journal of Pediatric Nursing·R B Monsen
Mar 27, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·S G Deeks
Aug 31, 2001·Bioorganic & Medicinal Chemistry Letters·D W LudoviciP A Janssen
Apr 18, 2002·Antimicrobial Agents and Chemotherapy·Raymond F SchinaziSusan Erickson-Viitanen
Jun 5, 2002·Journal of Clinical Pharmacology·Patrick F SmithCharles H Ballow
Oct 16, 2002·Trends in Pharmacological Sciences·Luis Menéndez-Arias
Dec 11, 2002·Expert Opinion on Therapeutic Targets·Carmela Giglione, Thierry Meinnel
Jun 7, 2003·Antiviral Chemistry & Chemotherapy·Susan Erickson-ViitanenRaymond F Schinazi
Feb 26, 2004·Antimicrobial Agents and Chemotherapy·Hwijin Kim, John Yin
Apr 6, 2004·International Journal of Medical Informatics·Jeannette MurphySue Davis
Apr 20, 2004·Current Opinion in Infectious Diseases·Anton Pozniak
May 6, 2004·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Erik De Clercq
Jun 29, 2004·The Lancet Infectious Diseases·David A Cooper, Joep M A Lange

❮ Previous
Next ❯

Citations

Aug 3, 2010·Bioorganic & Medicinal Chemistry·Manohar Sharma VedulaParthasaradhi Reddy Bandi
Dec 18, 2007·Bioorganic & Medicinal Chemistry Letters·Zhijian ZhaoTheresa M Williams
Nov 29, 2011·Annals of Physical and Rehabilitation Medicine·A Laurent-VannierUNKNOWN French National Authority for Health

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current HIV/AIDS Reports
Kimberly Hanson, Charles Hicks
International Journal of Clinical Practice
L WatersM Nelson
© 2022 Meta ULC. All rights reserved